Long-term efficacy and cost-effectiveness of infliximab as first-line treatment in rheumatoid arthritis: systematic review and meta-analysis

Absztrakt
Leírás
Kulcsszavak
Forrás
Expert Review of Pharmacoeconomics & Outcomes Research. -19 : 5 (2019), p. 537-549. -Expert Review of Pharmacoeconomics & Outcomes Research. - 1473-7167. - 1744-8379